4//SEC Filing
Heyman Tomas J. 4
Accession 0001415889-23-009740
CIK 0001840233other
Filed
Jun 12, 8:00 PM ET
Accepted
Jun 13, 4:30 PM ET
Size
5.4 KB
Accession
0001415889-23-009740
Insider Transaction Report
Form 4
Heyman Tomas J.
Director
Transactions
- Award
Stock Option (right to buy)
2023-06-12+13,200→ 13,200 totalExercise: $2.80Exp: 2033-06-11→ Common Stock (13,200 underlying)
Footnotes (1)
- [F1]The option was granted on June 12, 2023 and will vest as to 100% of the shares underlying the option on the earlier of (i) June 12, 2024 and (ii) the Issuer's next annual meeting of stockholders following the grant date, subject to the Reporting Person's continued service to the Issuer through the vesting date.
Documents
Issuer
Xilio Therapeutics, Inc.
CIK 0001840233
Entity typeother
Related Parties
1- filerCIK 0001814673
Filing Metadata
- Form type
- 4
- Filed
- Jun 12, 8:00 PM ET
- Accepted
- Jun 13, 4:30 PM ET
- Size
- 5.4 KB